®


You missed a spot.


STERIWAVE® NASAL PHOTODISINFECTION REVOLUTIONARY PATHOGEN REDUCTION 1 in 3 people carry S. aureus in their nose,1-2 a leading cause of


healthcare-associated infections. Steriwave is a revolutionary light-activated antimicrobial that destroysS. aureus and other nasal pathogens with a single, painless 5-minute treatment.


Proven to significantly reduce the incidence of infection, especially among high-risk patients, Steriwave has been administered over 150,000 times with no serious adverse effects and is relied upon by leading teaching hospitals in Canada.


Nasal decolonization for high-risk surgeries


ESSENTIAL PRACTICE RECOMMENDATION


3 - SHEA/IDSA/APIC - For more information visit: www.molnlycke.co.uk


1 Wertheim et al. Lancet Infect Dis (2005). 2 Septimus et al. Clin Microbiol Rev (2016).


3 Calderwood et al. Infect Control Hosp Epidemiol (2023).


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64